z-logo
Premium
Expression of coagulation factor V gene by normal adult human hepatocytes in primary culture
Author(s) -
Mazzorana Marlene,
Baffet Georges,
Kneip Bernard,
Launois Bernard,
GuguenGuillouzo Christiane
Publication year - 1991
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1991.tb04421.x
Subject(s) - northern blot , fibrinogen , albumin , microbiology and biotechnology , biology , western blot , hep g2 , messenger rna , immunoprecipitation , gene , factor v , secretion , coagulation , primary culture , endocrinology , medicine , cell culture , biochemistry , genetics , thrombosis
Summary Normal human adult hepatocytes were examined for their ability to synthesize and secrete factor V using primary culture. The culture medium contained both factor V and factor Va as determined by bioassay and activation experiments. Immunoprecipitation of newly synthesized labelled factor V showed the presence of both native factor V (m.w. 330000) and two fragments of respective molecular weight 3 and 265000. Northern blot analysis revealed the presence of a single 7 kb factor V mRNA in cultured human hepatocytes as in liver biopsies, together with fibrinogen β and albumin transcripts. Relative levels of factor V, fibrinogen β and albumin mRNAs differed when the cells cultured, suggesting that expression of the three corresponding genes might in part be independently regulated. Furthermore, addition of glucocorticoids enhanced factor V and fibrinogen β mRNA levels 1·6‐ and 5‐fold respectively, but did not significantly increase that of albumin. These results provide evidence that human hepatocytes actively participate in the synthesis of plasma factor V and constitute a valuable model to study the common and specific regulations involved in the control of the expression of this gene in human liver.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here